article thumbnail

Long-term Health-related Quality of Life and Rhythm-Outcomes of Catheter Ablation versus Antiarrhythmic Drugs in Patients with Atrial Fibrillation.

HeartRhythm

Data on long-term effects of catheter ablation versus antiarrhythmic drugs (AAD) on health-related quality of life (HRQoL) and atrial fibrillation (AF) burden are limited.

article thumbnail

Novel Tricuspid Valve Procedure Improves Patients' Quality of Life and Health Status

DAIC

For more information: [link] Related Content: Edwards Evoque Transcatheter Tricuspid Valve Replacement System Receives CE Mark Edwards Announces One-year Data on Transfemoral Transcatheter Tricuspid Valve Replacement Six-Month Outcomes Positive for Transfemoral Tricuspid Valve in Tricuspid Regurgitation Patients Edwards LifeSciences Reports (..)

Tricuspid 105
article thumbnail

Effects of 1-year exercise in patients with atrial fibrillation: study protocol for the Norwegian Exercise in Atrial Fibrillation (NEXAF) randomised controlled trial

Open Heart

Although lifestyle changes and risk factor modification are now acknowledged as central components of atrial fibrillation management, the effects of exercise on disease-specific outcomes are still not extensively documented due to few high-quality randomised trials.

article thumbnail

Quality of Life in Patients with Atopic Dermatitis and Patient-Reported Outcomes

HCPLive

Shawn Kwatra, MD, discusses the effects of poorly controlled or severe atopic dermatitis on patients’ quality of life and how to measure patient-reported outcomes.

article thumbnail

New Tool Helps Predict Stroke Outcome with Higher Accuracy

DAIC

By integrating a real-time frailty risk score into the electronic medical record (EMR), presenting stroke severity and other variables, we can proactively identify who will benefit from immediate surgery and who may need pre-habilitating before surgery to achieve better outcomes.

Stroke 52
article thumbnail

SUMMIT: Tirzepatide Improves Outcomes and Quality of Life For Patients With HFpEF and Obesity

American College of Cardiology

In patients with obesity and heart failure with preserved ejection fraction (HFpEF), weekly treatment with tirzepatide over approximately two years reduced the risk of worsening heart failure events, based on findings from the SUMMIT trial.

article thumbnail

CareDx Launches Two Expanded Indications for AlloSure Testing Services

DAIC

Simultaneous pancreas-kidney (SPK) transplants are known to improve the quality of life and long-term survival of patients with insulin dependent diabetes and advanced renal disease. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation. Clin Transplant.